Essential medicines and health products

Substandard and Falsified (SF) Medical Products

The existence of substandard and falsified (SF) medical products is an unacceptable risk to public health. They affect every region of the world, and medicines from all major therapeutic categories have been reported, including vaccines and diagnostics. They harm patients and undermine confidence in medical products, healthcare professionals and health systems. WHO is working with stakeholders to minimize the risks from SF medical products by collecting data and transferring knowledge and good practices to countries.


News and Announcements

We are pleased to announce two important WHO publications launched on 29 November 2017:

Please also find our most recent updates on the Seventieth World Health Assembly regarding the agreed working definitions of substandard and falsified medical products at the following links:

The SF Medical Products Group kindly asks for your patience as we work to update this website, as appropriate.
Please contact us at rapidalert@who.int should you have any questions.

Recent and Forthcoming Events

  • 30 November - 1 December, 2017

    6th Member State Mechanism Meeting

    Geneva, Switzerland

  • 29 November, 2017

    Member State Mechanism Steering Committee Meeting

    Geneva, Switzerland

  • 7-10 November, 2017

    National Workshop on the Prevention, Detection and Response to Substandard and Falsified Medical Products

    Naypyidaw, Myanmar

  • 2-6 October, 2017

    National Workshop on the Prevention, Detection and Response to Substandard and Falsified Medical Products

    Lagos, Nigeria

Contact us

SF Medical Products Group
Essential Medicines and Health Products
World Health Organization
20 avenue Appia
1211 Geneva 27
Switzerland
E-mail: rapidalert@who.int